Data / Drug companies / Dicyclomine hydrochloride
Dicyclomine hydrochloride: 50 companies and 129 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dicyclomine hydrochloride is listed in the FDA National Drug Code Directory by 50 companies, with 129 products in commercial distribution. 129 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; injection, solution, and the newest product started marketing on September 15, 2026.
The request: Get every company that lists dicyclomine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 50
- Products
- 129
- Generic (ANDA) products
- 129 (100.0%)
- Application numbers
- 30
- Routes
- Oral, Intramuscular
- Brand names
- Dicyclomine
- openFDA record search
- api.fda.gov
Companies that list dicyclomine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 13 | tablet; capsule | Generic drugs (ANDA) | November 15, 2024 |
| A-S Medication Solutions | 11 | tablet; capsule | Generic drugs (ANDA) | November 15, 2024 |
| Bryant Ranch Prepack | 8 | tablet; capsule | Generic drugs (ANDA) | September 13, 2023 |
| Redpharm Drug | 7 | tablet; capsule | Generic drugs (ANDA) | May 7, 2024 |
| Remedyrepack Inc. | 6 | tablet; capsule | Generic drugs (ANDA) | January 26, 2026 |
| Hikma Pharmaceuticals USA Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | September 15, 2026 |
| Northwind Health Company, LLC | 4 | tablet; capsule | Generic drugs (ANDA) | June 12, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | September 30, 2025 |
| Preferred Pharmaceuticals Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | August 12, 2026 |
| Advagen Pharma Ltd | 3 | tablet; capsule | Generic drugs (ANDA) | July 17, 2026 |
| Bryant Ranch Prepack | 3 | tablet; capsule | Generic drugs (ANDA) | May 8, 2023 |
| Coupler LLC | 3 | capsule; tablet | Generic drugs (ANDA) | April 28, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | July 30, 1986 |
| Proficient Rx LP | 3 | tablet; capsule | Generic drugs (ANDA) | February 26, 1999 |
| St. Mary's Medical Park Pharmacy | 3 | tablet | Generic drugs (ANDA) | December 30, 2024 |
| Actavis Pharma, Inc. | 2 | capsule; tablet | Generic drugs (ANDA) | July 30, 1986 |
| American Health Packaging | 2 | tablet; capsule | Generic drugs (ANDA) | December 6, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | February 26, 1999 |
| Aurobindo Pharma Limited | 2 | tablet; capsule | Generic drugs (ANDA) | May 8, 2023 |
| Camber Pharmaceuticals, Inc. | 2 | capsule; tablet | Generic drugs (ANDA) | July 1, 2024 |
| Cardinal Health 107, LLC | 2 | capsule | Generic drugs (ANDA) | October 4, 2018 |
| Chartwell RX, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | February 26, 1999 |
| Golden State Medical Supply, Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | June 1, 2023 |
| Lannett Company, Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | February 26, 1999 |
| Major Pharmaceuticals | 2 | capsule; tablet | Generic drugs (ANDA) | February 26, 1999 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet; capsule | Generic drugs (ANDA) | December 14, 2022 |
| Rising Pharma Holdings, Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | June 23, 2025 |
| Solaris Pharma Corporation | 2 | capsule; tablet | Generic drugs (ANDA) | June 10, 2025 |
| Somerset Therapeutics, LLC | 2 | injection, solution | Generic drugs (ANDA) | November 5, 2024 |
| Upsher-Smith Laboratories, LLC | 2 | tablet; capsule | Generic drugs (ANDA) | July 1, 2023 |
| American Regent, Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 1, 2017 |
| Ani Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | April 23, 2021 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | March 4, 2025 |
| AvPAK | 1 | capsule | Generic drugs (ANDA) | March 20, 2024 |
| Bionpharma Inc. | 1 | tablet | Generic drugs (ANDA) | September 13, 2023 |
| Fosun Pharma USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 30, 2019 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | September 12, 2019 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | Generic drugs (ANDA) | July 19, 2021 |
| Hikma Pharmaceuticals USA Inc. | 1 | tablet | Generic drugs (ANDA) | October 1, 1996 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection | Generic drugs (ANDA) | December 30, 2015 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | March 6, 2026 |
| NuCare Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | June 19, 1986 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | June 19, 1986 |
| Par Health USA, LLC | 1 | solution | Generic drugs (ANDA) | June 23, 2005 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | June 19, 1986 |
| QPharma, Inc. | 1 | capsule | Generic drugs (ANDA) | June 19, 1986 |
| Slate Run Pharmaceuticals, LLC | 1 | injection | Generic drugs (ANDA) | September 23, 2021 |
| Solco Healthcare US, LLC | 1 | capsule | Generic drugs (ANDA) | August 23, 2022 |
| Trifluent Pharma, LLC | 1 | tablet | Generic drugs (ANDA) | July 14, 2025 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 4, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 67 | 51.9% |
| Capsule | 50 | 38.8% |
| Injection, solution | 6 | 4.7% |
| Solution | 4 | 3.1% |
| Injection | 2 | 1.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 129 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Anticholinergic | 129 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.